PTC Therapeutics
Patents, Design & Utilities

Last updated:

List of all PTC Therapeutics patents 95 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS External link
Filling date: 7 Sep 2025 Issue date: 18 Aug 2022
Application
Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 7 Sep 2025 Issue date: 11 Aug 2022
Grant
Utility: Compounds for treating Huntington's disease External link
Filling date: 7 Sep 2025 Issue date: 9 Aug 2022
Grant
Utility: Methods for treating Huntington's disease External link
Filling date: 7 Sep 2025 Issue date: 26 Jul 2022
Grant
Utility: 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof External link
Filling date: 7 Sep 2025 Issue date: 19 Jul 2022
Application
Utility: 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 14 Jul 2022
Grant
Utility: Methods for treating Huntington's Disease External link
Filling date: 7 Sep 2025 Issue date: 12 Jul 2022
Application
Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 7 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF External link
Filling date: 7 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: DISPERSIBLE TABLET COMPOSITION External link
Filling date: 7 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: METHOD FOR TREATING NONSENSE MUTATION MEDIATED DUCHENNE MUSCULAR DYSTROPHY IN PEDIATRIC PATIENTS External link
Filling date: 7 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: NOVEL RNA TRANSCRIPT External link
Filling date: 7 Sep 2025 Issue date: 26 May 2022
Application
Utility: TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME External link
Filling date: 7 Sep 2025 Issue date: 19 May 2022
Application
Utility: COMBINATIONS USEFUL IN A METHOD FOR TREATING SARCOMA External link
Filling date: 7 Sep 2025 Issue date: 19 May 2022
Application
Utility: VECTOR AND METHOD FOR TREATING ANGELMAN SYNDROME External link
Filling date: 7 Sep 2025 Issue date: 19 May 2022
Application
Utility: METHOD FOR TREATING A MULTIPLE MYELOMA External link
Filling date: 7 Sep 2025 Issue date: 12 May 2022
Application
Utility: TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES External link
Filling date: 7 Sep 2025 Issue date: 5 May 2022
Application
Utility: THIOENO[3,2-B] PYRIDIN-7-AMINE COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA External link
Filling date: 7 Sep 2025 Issue date: 5 May 2022
Application
Utility: PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA External link
Filling date: 7 Sep 2025 Issue date: 5 May 2022
Grant
Utility: Process for the production of alpha-tocotrienol and derivatives External link
Filling date: 7 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide External link
Filling date: 7 Sep 2025 Issue date: 19 Apr 2022
Application
Utility: 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 7 Apr 2022
Application
Utility: REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS External link
Filling date: 7 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS External link
Filling date: 7 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 7 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Methods for enriching alpha-tocotrienol from mixed tocol compositions External link
Filling date: 7 Sep 2025 Issue date: 30 Nov 2021
Application
Utility: METHODS OF ADMINISTERING DEFLAZACORT THERAPY External link
Filling date: 7 Sep 2025 Issue date: 25 Nov 2021
Grant
Utility: Substituted reverse pyrimidine Bmi-1 inhibitors External link
Filling date: 7 Sep 2025 Issue date: 23 Nov 2021
Grant
Utility: 2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders External link
Filling date: 7 Sep 2025 Issue date: 16 Nov 2021
Application
Utility: CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE External link
Filling date: 7 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS External link
Filling date: 7 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 7 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: METHODS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 7 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY External link
Filling date: 7 Sep 2025 Issue date: 9 Sep 2021
Grant
Utility: Methods of administering deflazacort therapy External link
Filling date: 7 Sep 2025 Issue date: 10 Aug 2021
Application
Utility: FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: METHOD FOR TREATING PANCREATIC CANCER External link
Filling date: 7 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE External link
Filling date: 7 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: BIOAVAILABLE ORAL DOSAGE FORMS External link
Filling date: 7 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES External link
Filling date: 7 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY External link
Filling date: 7 Sep 2025 Issue date: 20 May 2021
Application
Utility: TREATMENT OF METHYLMALONIC ACIDURIA, ISOVALERIC ACIDURIA, AND OTHER ORGANIC ACIDURIAS WITH TOCOTRIENOL QUINONES External link
Filling date: 7 Sep 2025 Issue date: 20 May 2021
Application
Utility: TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS External link
Filling date: 7 Sep 2025 Issue date: 6 May 2021
Grant
Utility: Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders External link
Filling date: 7 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases External link
Filling date: 7 Sep 2025 Issue date: 6 Apr 2021
Grant
Utility: Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease External link
Filling date: 7 Sep 2025 Issue date: 30 Mar 2021
Grant
Utility: Processes for the preparation of substituted tetrahydro beta-carbolines External link
Filling date: 7 Sep 2025 Issue date: 16 Mar 2021
Application
Utility: METHODS FOR MODULATING RNA SPLICING External link
Filling date: 7 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: 2-SUBSTITUTED AMINO-NAPHTH (1,2-D) IMIDAZOL-5-ONE COMPOUNDS OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF External link
Filling date: 7 Sep 2025 Issue date: 4 Mar 2021

Showing 1 to 50 of 95 patents.